Results 101 to 110 of about 7,850 (120)
Some of the next articles are maybe not open access.

Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

Journal of Hepatology, 2021
Camilla Stephens   +2 more
exaly  

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment

Metabolites, 2022
Marta Moreno-Torres   +2 more
exaly  

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method

International Journal of Molecular Sciences, 2022
Rolf Teschke   +2 more
exaly  

Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review

Expert Opinion on Drug Metabolism and Toxicology, 2021
Edmond Atallah   +2 more
exaly  

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Archives of Toxicology, 2021
Guillermo Quintás   +2 more
exaly  

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice

Antioxidants, 2021
Marina Villanueva Paz, Cristiana Freixo
exaly  

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

International Journal of Molecular Sciences, 2016
Fernando Bessone   +2 more
exaly  

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

Toxicology in Vitro, 2015
Simone Schadt   +2 more
exaly  

Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis

Journal of Hepatology, 2011
M Isabel Lucena, N Kaplowitz, H Hallal
exaly  

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019

Frontiers in Pharmacology, 2019
Rolf Teschke, Teschke Rolf
exaly  
mecmua
previous   9  10  11  12  

Home - About - Disclaimer - Privacy